Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve atrial fibrillation (AF) treatments, miniaturized diagnostic monitoring systems, and new implantable rhythm management devices that are making procedures much less invasive. According to latest analysis by Gen Consulting Company, the global electrophysiology devices market is projected to climb to USD 15,946 million by 2028-end, progressing at a CAGR of 8.9% during 2022-2028.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, and region. The global market data on electrophysiology devices can be segmented by product: catheters, electrophysiology (EP) lab devices, others. Electrophysiology devices market is further segmented by region: North America, Asia Pacific, Europe, Rest of the World (ROW).
The catheters market is further segmented into ablation catheters, diagnostic catheters. Furthermore, the EP lab devices market has been categorized into 3D mapping systems, cardiac stimulators, electrophysiology (EP) recording systems, intracardiac echocardiography (ICE) systems, radiofrequency ablation generators.
The global electrophysiology devices market is highly competitive. Some of the leading companies operating in the market are Abbott Laboratories, Acutus Medical Inc., AtriCure Inc., Baylis Medical Company Inc., Biosense Webster Inc. (Johnson & Johnson), BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CardioFocus Inc., General Electric Company, Japan Lifeline Co. Ltd., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, OSYPKA AG, Stereotaxis Inc., Vanguard AG.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
– Get a detailed picture of the Global Electrophysiology Devices Market
– Identify segments/areas to invest in over the forecast period in the Global Electrophysiology Devices Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 8.9% |
| Pages | 24 |
| Key Players | Abbott Laboratories, Acutus Medical Inc., AtriCure Inc., Baylis Medical Company Inc., Biosense Webster Inc. (Johnson & Johnson), BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CardioFocus Inc., General Electric Company, Japan Lifeline Co. Ltd., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, OSYPKA AG, Stereotaxis Inc., Vanguard AG |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
